ChatDocto
Find a doctor
White scored tablet

BI-SPIROGYL 1.5 MUI/250 mg

SPIRAMYCINE+METRONIDAZOLE · film-coated tablets

B/500Oral use
See all pack prices
Strength1.5 MUI/250 mg
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
ATC codeJ01RA04

About this medicine

BI-SPIROGYL 1.5 MUI/250 mg film-coated tablets is listed in Tunisia's medicine catalog under the active ingredient SPIRAMYCINE+METRONIDAZOLE. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/500

    500 units in this pack

    Price not recorded
    AMM No.
    9003813H
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formfilm-coated tablets
Route of administrationOral use
LaboratorySIPHAT
OriginGeneric
ScheduleA
ATC codeJ01RA04 — Spiramycine et métronidazole
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE